Clinical Trial Update: Efficacy and Safety of Repaglinide Combined With Insulin in Type 2 Diabetes [Phase 4]

View source ↗

Summary

This phase 4 clinical trial update assesses the efficacy and safety of combining repaglinide with insulin in patients with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)
• Repaglinide (Repaglinide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED